ClinicalTrials.Veeva
Menu

Find clinical trials for Triple Negative Breast Cancer in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Triple Negative Breast Cancer trials near Indianapolis, IN, USA:

Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers

and to evaluate the efficacy of this combination in advanced HER2 negative breast cancer that is triple negative...

Active, not recruiting
TNBC - Triple-Negative Breast Cancer
Drug: Talazoparib
Drug: Gedatolisib

Phase 1, Phase 2

Kari Wisinski

Indianapolis, Indiana, United States and 4 other locations

of care (SOC) chemotherapy monotherapy vs. SOC chemotherapy combined with tocilizumab in in Black and non-Black patients with metastatic triple...

Enrolling
Estrogen-receptor-low Breast Cancer
Metastatic Breast Cancer
Drug: Tocilizumab
Drug: SOC Chemotherapy

Phase 2

Kathy Miller

Indianapolis, Indiana, United States and 3 other locations

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

Enrolling
Triple Negative Breast Cancer
Drug: Capecitabine
Drug: Sacituzumab govitecan-hziy (SG)

Phase 3

Gilead Sciences
Gilead Sciences

Indianapolis, Indiana, United States of America and 223 other locations

levels in combination with chemotherapeutic agents in the first- and second-line treatment of participants with locally advanced/metastatic triple...

Enrolling
Locally Advanced Breast Cancer
Metastatic Triple Negative Breast Cancers
Drug: BNT327 Equivalent Q3W Dose
Drug: BNT327 Dose Level 1 (DL2)

Phase 2

BioNTech
BioNTech

Indianapolis, Indiana, United States and 61 other locations

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell Lung Cancer (NSCLC) ...

Enrolling
Gastric/Esophageal Cancer
Micro Satellite Stable Colorectal Cancer
Drug: Bevacizumab
Drug: Azirkitug

Phase 1

AbbVie
AbbVie

Indianapolis, Indiana, United States and 28 other locations

The purpose of this study is to measure the safety and efficacy of LY4175408 in participants with selected advanced cancer. In addition, thi...

Not yet enrolling
Neoplasm Metastasis
Triple Negative Breast Cancer
Drug: LY4175408

Phase 1

Lilly
Lilly

Indianapolis, Indiana, United States and 20 other locations

The primary objective of this study is to evaluate the safety, tolerability, MTD and RP2D of LP-184 in patients with advanced solid tumors w...

Enrolling
TNBC - Triple-Negative Breast Cancer
Advanced Solid Tumor
Drug: Olaparib
Drug: LP-184

Phase 1, Phase 2

Lantern Pharma

Indianapolis, Indiana, United States and 8 other locations

including metastatic colorectal cancer (mCRC) patients....

Enrolling
Cancer
Drug: cetuximab
Drug: FOLFIRI

Phase 1

Tizona Therapeutics

Indianapolis, Indiana, United States and 38 other locations

This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers...

Enrolling
Squamous Non-small-cell Lung Cancer
Advanced Solid Tumor
Drug: VLS-1488

Phase 1, Phase 2

Volastra Therapeutics

Indianapolis, Indiana, United States and 12 other locations

in participants with locally advanced or metastatic solid tumors harboring a TP53 Y220C mutation. The Phase 1 portion of the study will asse...

Enrolling
Small Cell Lung Cancer
Gall Bladder Cancer
Drug: rezatapopt
Drug: pembrolizumab

Phase 1, Phase 2

PMV Pharmaceuticals

Indianapolis, Indiana, United States and 76 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems